Friday's top brokerage calls: Finolex Cables, Bharti Airtel and more

SUMMARY

Among brokerages, Jefferies maintains 'buy' on Finolex Cables while Macquarie has an 'outperform' call for Bharti Airtel. Credit Suisse and Citi are bullish on Dr Reddy's. Here are the top brokerage calls for the day:

By CNBCTV18.comSept 18, 2020 9:02:53 AM IST (Published)

Jefferies on Finolex Cables: The brokerage maintains a 'buy' call on the stock with a target at Rs 415 per share. It likes the company’s focus on margin-accretive electrical cables and inexpensive valuation.

Macquarie on Bharti Airtel: The brokerage has an 'outperform' call on the stock with a target at Rs 700 per share. It says recent checks show the possibility of a tariff increase later in 2020.

Credit Suisse on Dr Reddy's: The brokerage maintains 'outperform' call on the stock and raised the target to Rs 5,750 per share from Rs 5,100 earlier.

Citi on Dr Reddy's: The brokerage has a 'buy' call on the stock with a target at Rs 500 per share. It assumes that the company will be able to launch Revlimid generic in September 2022.

Macquarie on Cipla & Lupin: The brokerage says setback for Perrigo comes as an unexpected positive for Lupin & Cipla. Both companies are Perrigo’s competitors in $850-900 million US Albuterol Sulfate market.

CLSA on IT Services: As per the brokerage, forex swings will impact EPS forecasts but it sees limited stock implications. Infosys and HCL Tech remain CLSA's bottom-up sector picks.

CLSA on Auto: The brokerage notes that the market is concerned about the attendant risk of a significant capital call on the OEMs.